Nathan De Beule

Academic, Clinical sciences
UZB Physician, Hematology
Hematology

Laarbeeklaan 101
1090 Brussels
Belgium
Laarbeeklaan 101
1090 Jette
Belgium

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Nathan De Beule is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

185 Citations
6 h-Index
8 Article
7 Meeting abstract (Journal)
2 Meeting abstract (Book)
1 Poster
More
- 1 Conference paper
- 1 Scientific review

AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers
Vlummens, P., De Beule, N., Faict, S., Oudaert, I., Maes, K., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 14 Feb 2020, In : Belgian Journal of Hematology. 11, O2, p. 9-9 1 p., 11.
Research output: Contribution to journal › Meeting abstract (Journal)
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma
Yan, S., Vandewalle, N., De Beule, N., Faict, S., Maes, K., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 5 Nov 2019, In : Cancers. 11, 11, p. 1-17 17 p., 1727.
Research output: Contribution to journal › Scientific review
8 Citations (Scopus)
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway
De Veirman, K., Menu, E., Maes, K., De Beule, N., De Smedt, E., Maes, A., Vlummens, P., Fostier, K., Kassambara, A., Moreaux, J., Van Ginderachter, J. A., De Bruyne, E., Vanderkerken, K. & Van Valckenborgh, E., 1 Feb 2019, In : Cancer Letters. 442, p. 233-241 9 p.
Research output: Contribution to journal › Article
19 Citations (Scopus)
Receptor Tyrosine Kinase AXL: A potential new target in Multiple Myeloma
De Veirman, K., De Beule, N., Faict, S., Maes, K., De Bruyne, E., Menu, E. & Vanderkerken, K., 1 Feb 2019, In : Belgian Journal of Hematology. 10, 19.
Research output: Contribution to journal › Meeting abstract (Journal)
Receptor Tyrosine Kinase AXL: A Potential Strategy to Counter Immune Suppression and Dormancy in Multiple Myeloma
De Veirman, K., Maes, K., De Beule, N., Faict, S., De Bruyne, E., Menu, E. & Vanderkerken, K., 13 Nov 2019, In : Blood. 134, 4335.
Research output: Contribution to journal › Meeting abstract (Journal)

Open Access

1 Participation in conference
1 Participation in workshop, seminar

28th General Annual Meeting of the Belgian Hematological Society
Nathan De Beule (Participant)
24 Jan 2013 → 26 Jan 2013
Activity: Participating in or organising an event › Participation in conference
Multiple Myeloma and Related Malignancies, 2nd edition
Nathan De Beule (Participant)
7 Nov 2013 → 9 Nov 2013
Activity: Participating in or organising an event › Participation in workshop, seminar

Bone marrow-induced survival: identifying novel targets in multiple myeloma.
Author: De Beule, N., Vanderkerken, K., Schots, H., Menu, E., Van Valckenborgh, E., Neyns, B., Van Riet, I., Laoui, D., Pals, S. & Offner, F., 24 Apr 2018
Supervisor: Vanderkerken, K. (Promotor), Schots, H. (Promotor), Menu, E. (Promotor), Van Valckenborgh, E. (Promotor), Neyns, B. (Jury), Van Riet, I. (Jury), Laoui, D. (Jury), Pals, S. (External person) (Jury) & Offner, F. (External person) (Jury)
Student thesis: Doctoral Thesis